Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study.
暂无分享,去创建一个
S. Garland | J. Hocking | M. Law | S. Tabrizi | C. Fairley | C. Bradshaw | H. Zou | G. Prestage | A. Grulich | Marcus Y. Chen | A. Cornall | Andrea Morrow
[1] Deborah Bateson,et al. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. , 2014, The Lancet. Infectious diseases.
[2] B. Clotet,et al. Oral human papillomavirus type-specific infection in HIV-infected men: a prospective cohort study among men who have sex with men and heterosexual men. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[3] S. Garland,et al. Sexual behaviors and risk for sexually transmitted infections among teenage men who have sex with men. , 2014, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[4] S. Garland,et al. How very young men who have sex with men view vaccination against human papillomavirus. , 2014, Vaccine.
[5] S. Garland,et al. Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. , 2014, The Journal of infectious diseases.
[6] M. Golden,et al. High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men. , 2014, The Journal of infectious diseases.
[7] J. Palefsky,et al. Anal Human Papillomavirus Infection Among Thai Men Who Have Sex With Men With and Without HIV Infection: Prevalence, Incidence, and Persistence , 2013, Journal of acquired immune deficiency syndromes.
[8] B. Clotet,et al. Prevalence, Clearance, and Incidence of Human Papillomavirus Type–Specific Infection at the Anal and Penile Site of HIV-Infected Men , 2013, Sexually transmitted diseases.
[9] J. Palefsky,et al. High prevalence and incidence of high-grade anal intraepithelial neoplasia among young Thai men who have sex with men with and without HIV , 2013, AIDS.
[10] E. Sugar,et al. Natural history of anal vs oral HPV infection in HIV-infected men and women. , 2013, The Journal of infectious diseases.
[11] R. Guy,et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data , 2013, BMJ : British Medical Journal.
[12] B. Clotet,et al. Natural History of Human Papillomavirus Infections Involving Anal, Penile, and Oral Sites Among HIV-Positive Men , 2013, Sexually transmitted diseases.
[13] S. Garland,et al. The prevalence of anal human papillomavirus among young HIV negative men who have sex with men , 2012, BMC Infectious Diseases.
[14] S. Garland,et al. Oral Human Papillomavirus in Men Having Sex with Men: Risk-Factors and Sampling , 2012, PloS one.
[15] B. Clotet,et al. Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV‐infected men , 2012, HIV medicine.
[16] B. Graubard,et al. Prevalence of oral HPV infection in the United States, 2009-2010. , 2012, JAMA.
[17] A. Giuliano,et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. , 2011, The Journal of infectious diseases.
[18] A. Burchell,et al. Genital transmission of human papillomavirus in recently formed heterosexual couples. , 2011, The Journal of infectious diseases.
[19] H. Jessen,et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. , 2011, The New England journal of medicine.
[20] L. Dodd,et al. Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure , 2011, Sexually transmitted diseases.
[21] M. Pawlita,et al. Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa. , 2011, The Journal of general virology.
[22] Masha Fridman,et al. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study , 2011, The Lancet.
[23] G. Palù,et al. Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men , 2011, BMC infectious diseases.
[24] H. Jessen,et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. , 2011, The New England journal of medicine.
[25] E. Franco,et al. Episomal and integrated human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive men , 2010, AIDS.
[26] P. Coursaget,et al. Seroprevalence of Antibodies against Human Papillomavirus (HPV) Types 16 and 18 in Four Continents: the International Agency for Research on Cancer HPV Prevalence Surveys , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[27] M. Schiffman,et al. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline , 2009, Infectious Agents and Cancer.
[28] E. Franco,et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. , 2009, The Journal of infectious diseases.
[29] J. Kaldor,et al. Risk Factors for Genital and Anal Warts in a Prospective Cohort of HIV-Negative Homosexual Men: The HIM Study , 2006, Sexually transmitted diseases.
[30] A. Osterhaus,et al. Acquisition and clearance of perianal human papillomavirus infection in relation to HIV-positivity in men who have sex with men in the Netherlands. , 2005, Acta dermato-venereologica.
[31] M. Pagano,et al. Skp2, the FoxO1 hunter. , 2005, Cancer cell.
[32] N. Kiviat,et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. , 2003, American journal of epidemiology.
[33] Almut Scherer,et al. Mathematical models of vaccination. , 2002, British medical bulletin.
[34] S. Garland,et al. Cervical adenoid basal carcinoma, five cases and literature review , 1996 .
[35] A. Reingold,et al. Genital human papillomavirus infection in female university students as determined by a PCR‐based method , 1991, JAMA.
[36] H. Fox,et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. , 1990, Journal of the National Cancer Institute.
[37] K Ulm,et al. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR) , 1990, American journal of epidemiology.
[38] H. Jessen,et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. , 2011, The Journal of infectious diseases.
[39] R. Guy,et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. , 2011, The Lancet. Infectious diseases.
[40] O. Diekmann,et al. On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations , 1990, Journal of mathematical biology.
[41] Steven Wolinsky,et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses , 1989 .